APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Plant Sources Anti Cancer Agents

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Plant Sources Anti Cancer Agents Market Analysis and Forecast 2026-2032

Report ID 174026340222 December 2025200 pages

Choose your research edition.

Industry ResearchPlant Sources Anti Cancer Agents Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Plant Sources Anti Cancer Agents Industry Growth and Trends Forecast to 2032115 pages · $3,450 USDMarket StructureGlobal Plant Sources Anti Cancer Agents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Plant Sources Anti Cancer Agents Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Plant Sources Anti Cancer Agents Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Plant Sources Anti Cancer Agents market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Plant Sources Anti Cancer Agents is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Plant Sources Anti Cancer Agents is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Plant Sources Anti Cancer Agents is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Plant Sources Anti Cancer Agents is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Plant Sources Anti Cancer Agents include Yunnan Hande, Pfizer, Hainan Yew Pharm, West-Ward Pharmaceuticals, TAPI (Teva), Taj Pharma, Southpharma, ScinoPharm and Samyang, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Plant Sources Anti Cancer Agents, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Plant Sources Anti Cancer Agents, also provides the sales of main regions and countries. Of the upcoming market potential for Plant Sources Anti Cancer Agents, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Plant Sources Anti Cancer Agents sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Plant Sources Anti Cancer Agents market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Plant Sources Anti Cancer Agents sales, projected growth trends, production technology, application and end-user industry.

Plant Sources Anti Cancer Agents Segment by Company

Yunnan Hande

Pfizer

Hainan Yew Pharm

West-Ward Pharmaceuticals

TAPI (Teva)

Taj Pharma

Southpharma

ScinoPharm

Samyang

Salius

Polymed

Phyton

Novasep

Jiangsu Yew Biotechnology

Huiang biopharma

Getwell

Fresenius-kabi

Cipla

Actiza Pharmaceutical

Plant Sources Anti Cancer Agents Segment by Type

Paclitaxel

Vinorelbine

Irinotecan

Hydroxycamptothecin

Docetaxel

Other

Plant Sources Anti Cancer Agents Segment by Application

Breast Cancer

Ovarian Cancer

Cervical Cancer

Other

Plant Sources Anti Cancer Agents Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plant Sources Anti Cancer Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Plant Sources Anti Cancer Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plant Sources Anti Cancer Agents.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Plant Sources Anti Cancer Agents in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Plant Sources Anti Cancer Agents manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Plant Sources Anti Cancer Agents sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Plant Sources Anti Cancer Agents Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Paclitaxel Major Manufacturers Table 3. Vinorelbine Major Manufacturers Table 4. Irinotecan Major Manufacturers Table 5. Hydroxycamptothecin Major Manufacturers Table 6. Docetaxel Major Manufacturers Table 7. Other Major Manufacturers Table 8. Global Plant Sources Anti Cancer Agents Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Breast Cancer Major Manufacturers Table 10. Ovarian Cancer Major Manufacturers Table 11. Cervical Cancer Major Manufacturers Table 12. Other Major Manufacturers Table 13. Plant Sources Anti Cancer Agents Industry Trends Table 14. Plant Sources Anti Cancer Agents Industry Drivers Table 15. Plant Sources Anti Cancer Agents Industry Opportunities and Challenges Table 16. Plant Sources Anti Cancer Agents Industry Restraints Table 17. Global Plant Sources Anti Cancer Agents Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Plant Sources Anti Cancer Agents Revenue by Region (2021-2026) & (US$ Million) Table 19. Global Plant Sources Anti Cancer Agents Revenue by Region (2027-2032) & (US$ Million) Table 20. Global Plant Sources Anti Cancer Agents Revenue Market Share by Region (2021-2026) Table 21. Global Plant Sources Anti Cancer Agents Revenue Market Share by Region (2027-2032) Table 22. Global Plant Sources Anti Cancer Agents Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (tons) Table 23. Global Plant Sources Anti Cancer Agents Sales by Region (2021-2026) & (tons) Table 24. Global Plant Sources Anti Cancer Agents Sales by Region (2027-2032) & (tons) Table 25. Global Plant Sources Anti Cancer Agents Sales Market Share by Region (2021-2026) Table 26. Global Plant Sources Anti Cancer Agents Sales Market Share by Region (2027-2032) Table 27. Global Plant Sources Anti Cancer Agents Revenue by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Plant Sources Anti Cancer Agents Revenue Market Share by Manufacturers (2021-2026) Table 29. Global Plant Sources Anti Cancer Agents Sales by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Plant Sources Anti Cancer Agents Sales Market Share by Manufacturers (2021-2026) Table 31. Global Plant Sources Anti Cancer Agents Sales Price (US$/kg) of Manufacturers (2021-2026) Table 32. Global Plant Sources Anti Cancer Agents Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 33. Global Plant Sources Anti Cancer Agents Key Manufacturers Manufacturing Sites & Headquarters Table 34. Global Plant Sources Anti Cancer Agents Manufacturers, Product Type & Application Table 35. Global Plant Sources Anti Cancer Agents Manufacturers' Establishment Date Table 36. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 37. Global Plant Sources Anti Cancer Agents by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 38. Global Plant Sources Anti Cancer Agents Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Plant Sources Anti Cancer Agents Revenue by Type (2021-2026) & (US$ Million) Table 40. Global Plant Sources Anti Cancer Agents Revenue by Type (2027-2032) & (US$ Million) Table 41. Global Plant Sources Anti Cancer Agents Revenue Market Share by Type (2021-2026) Table 42. Global Plant Sources Anti Cancer Agents Revenue Market Share by Type (2027-2032) Table 43. Global Plant Sources Anti Cancer Agents Sales by Type 2021 VS 2025 VS 2032 (tons) Table 44. Global Plant Sources Anti Cancer Agents Sales by Type (2021-2026) & (tons) Table 45. Global Plant Sources Anti Cancer Agents Sales by Type (2027-2032) & (tons) Table 46. Global Plant Sources Anti Cancer Agents Sales Market Share by Type (2021-2026) Table 47. Global Plant Sources Anti Cancer Agents Sales Market Share by Type (2027-2032) Table 48. Global Plant Sources Anti Cancer Agents Price by Type (2021-2026) & (US$/kg) Table 49. Global Plant Sources Anti Cancer Agents Price by Type (2027-2032) & (US$/kg) Table 50. Global Plant Sources Anti Cancer Agents Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Plant Sources Anti Cancer Agents Revenue by Application (2021-2026) & (US$ Million) Table 52. Global Plant Sources Anti Cancer Agents Revenue by Application (2027-2032) & (US$ Million) Table 53. Global Plant Sources Anti Cancer Agents Revenue Market Share by Application (2021-2026) Table 54. Global Plant Sources Anti Cancer Agents Revenue Market Share by Application (2027-2032) Table 55. Global Plant Sources Anti Cancer Agents Sales by Application 2021 VS 2025 VS 2032 (tons) Table 56. Global Plant Sources Anti Cancer Agents Sales by Application (2021-2026) & (tons) Table 57. Global Plant Sources Anti Cancer Agents Sales by Application (2027-2032) & (tons) Table 58. Global Plant Sources Anti Cancer Agents Sales Market Share by Application (2021-2026) Table 59. Global Plant Sources Anti Cancer Agents Sales Market Share by Application (2027-2032) Table 60. Global Plant Sources Anti Cancer Agents Price by Application (2021-2026) & (US$/kg) Table 61. Global Plant Sources Anti Cancer Agents Price by Application (2027-2032) & (US$/kg) Table 62. Yunnan Hande Company Information Table 63. Yunnan Hande Business Overview Table 64. Yunnan Hande Plant Sources Anti Cancer Agents Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 65. Yunnan Hande Plant Sources Anti Cancer Agents Product Portfolio Table 66. Yunnan Hande Recent Development Table 67. Pfizer Company Information Table 68. Pfizer Business Overview Table 69. Pfizer Plant Sources Anti Cancer Agents Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 70. Pfizer Plant Sources Anti Cancer Agents Product Portfolio Table 71. Pfizer Recent Development Table 72. Hainan Yew Pharm Company Information Table 73. Hainan Yew Pharm Business Overview Table 74. Hainan Yew Pharm Plant Sources Anti Cancer Agents Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 75. Hainan Yew Pharm Plant Sources Anti Cancer Agents Product Portfolio Table 76. Hainan Yew Pharm Recent Development Table 77. West-Ward Pharmaceuticals Company Information Table 78. West-Ward Pharmaceuticals Business Overview Table 79. West-Ward Pharmaceuticals Plant Sources Anti Cancer Agents Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 80. West-Ward Pharmaceuticals Plant Sources Anti Cancer Agents Product Portfolio Table 81. West-Ward Pharmaceuticals Recent Development Table 82. TAPI (Teva) Company Information Table 83. TAPI (Teva) Business Overview Table 84. TAPI (Teva) Plant Sources Anti Cancer Agents Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 85. TAPI (Teva) Plant Sources Anti Cancer Agents Product Portfolio Table 86. TAPI (Teva) Recent Development Table 87. Taj Pharma Company Information Table 88. Taj Pharma Business Overview Table 89. Taj Pharma Plant Sources Anti Cancer Agents Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 90. Taj Pharma Plant Sources Anti Cancer Agents Product Portfolio Table 91. Taj Pharma Recent Development Table 92. Southpharma Company Information Table 93. Southpharma Business Overview Table 94. Southpharma Plant Sources Anti Cancer Agents Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 95. Southpharma Plant Sources Anti Cancer Agents Product Portfolio Table 96. Southpharma Recent Development Table 97. ScinoPharm Company Information Table 98. ScinoPharm Business Overview Table 99. ScinoPharm Plant Sources Anti Cancer Agents Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 100. ScinoPharm Plant Sources Anti Cancer Agents Product Portfolio Table 101. ScinoPharm Recent Development Table 102. Samyang Company Information Table 103. Samyang Business Overview Table 104. Samyang Plant Sources Anti Cancer Agents Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 105. Samyang Plant Sources Anti Cancer Agents Product Portfolio Table 106. Samyang Recent Development Table 107. Salius Company Information Table 108. Salius Business Overview Table 109. Salius Plant Sources Anti Cancer Agents Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 110. Salius Plant Sources Anti Cancer Agents Product Portfolio Table 111. Salius Recent Development Table 112. Polymed Company Information Table 113. Polymed Business Overview Table 114. Polymed Plant Sources Anti Cancer Agents Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 115. Polymed Plant Sources Anti Cancer Agents Product Portfolio Table 116. Polymed Recent Development Table 117. Phyton Company Information Table 118. Phyton Business Overview Table 119. Phyton Plant Sources Anti Cancer Agents Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 120. Phyton Plant Sources Anti Cancer Agents Product Portfolio Table 121. Phyton Recent Development Table 122. Novasep Company Information Table 123. Novasep Business Overview Table 124. Novasep Plant Sources Anti Cancer Agents Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 125. Novasep Plant Sources Anti Cancer Agents Product Portfolio Table 126. Novasep Recent Development Table 127. Jiangsu Yew Biotechnology Company Information Table 128. Jiangsu Yew Biotechnology Business Overview Table 129. Jiangsu Yew Biotechnology Plant Sources Anti Cancer Agents Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 130. Jiangsu Yew Biotechnology Plant Sources Anti Cancer Agents Product Portfolio Table 131. Jiangsu Yew Biotechnology Recent Development Table 132. Huiang biopharma Company Information Table 133. Huiang biopharma Business Overview Table 134. Huiang biopharma Plant Sources Anti Cancer Agents Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 135. Huiang biopharma Plant Sources Anti Cancer Agents Product Portfolio Table 136. Huiang biopharma Recent Development Table 137. Getwell Company Information Table 138. Getwell Business Overview Table 139. Getwell Plant Sources Anti Cancer Agents Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 140. Getwell Plant Sources Anti Cancer Agents Product Portfolio Table 141. Getwell Recent Development Table 142. Fresenius-kabi Company Information Table 143. Fresenius-kabi Business Overview Table 144. Fresenius-kabi Plant Sources Anti Cancer Agents Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 145. Fresenius-kabi Plant Sources Anti Cancer Agents Product Portfolio Table 146. Fresenius-kabi Recent Development Table 147. Cipla Company Information Table 148. Cipla Business Overview Table 149. Cipla Plant Sources Anti Cancer Agents Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 150. Cipla Plant Sources Anti Cancer Agents Product Portfolio Table 151. Cipla Recent Development Table 152. Actiza Pharmaceutical Company Information Table 153. Actiza Pharmaceutical Business Overview Table 154. Actiza Pharmaceutical Plant Sources Anti Cancer Agents Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 155. Actiza Pharmaceutical Plant Sources Anti Cancer Agents Product Portfolio Table 156. Actiza Pharmaceutical Recent Development Table 157. North America Plant Sources Anti Cancer Agents Revenue by Type (2021-2026) & (US$ Million) Table 158. North America Plant Sources Anti Cancer Agents Revenue by Type (2027-2032) & (US$ Million) Table 159. North America Plant Sources Anti Cancer Agents Sales by Type (2021-2026) & (tons) Table 160. North America Plant Sources Anti Cancer Agents Sales by Type (2027-2032) & (tons) Table 161. North America Plant Sources Anti Cancer Agents Sales Price by Type (2021-2026) & (US$/kg) Table 162. North America Plant Sources Anti Cancer Agents Sales Price by Type (2027-2032) & (US$/kg) Table 163. North America Plant Sources Anti Cancer Agents Revenue by Application (2021-2026) & (US$ Million) Table 164. North America Plant Sources Anti Cancer Agents Revenue by Application (2027-2032) & (US$ Million) Table 165. North America Plant Sources Anti Cancer Agents Sales by Application (2021-2026) & (tons) Table 166. North America Plant Sources Anti Cancer Agents Sales by Application (2027-2032) & (tons) Table 167. North America Plant Sources Anti Cancer Agents Sales Price by Application (2021-2026) & (US$/kg) Table 168. North America Plant Sources Anti Cancer Agents Sales Price by Application (2027-2032) & (US$/kg) Table 169. North America Plant Sources Anti Cancer Agents Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 170. North America Plant Sources Anti Cancer Agents Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 171. North America Plant Sources Anti Cancer Agents Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 172. North America Plant Sources Anti Cancer Agents Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 173. North America Plant Sources Anti Cancer Agents Sales by Country (2021-2026) & (tons) Table 174. North America Plant Sources Anti Cancer Agents Sales by Country (2027-2032) & (tons) Table 175. North America Plant Sources Anti Cancer Agents Sales Price by Country (2021-2026) & (US$/kg) Table 176. North America Plant Sources Anti Cancer Agents Sales Price by Country (2027-2032) & (US$/kg) Table 177. United States Plant Sources Anti Cancer Agents Revenue (2021-2032) & (US$ Million) Table 178. Canada Plant Sources Anti Cancer Agents Revenue (2021-2032) & (US$ Million) Table 179. Mexico Plant Sources Anti Cancer Agents Revenue (2021-2032) & (US$ Million) Table 180. Europe Plant Sources Anti Cancer Agents Revenue by Type (2021-2026) & (US$ Million) Table 181. Europe Plant Sources Anti Cancer Agents Revenue by Type (2027-2032) & (US$ Million) Table 182. Europe Plant Sources Anti Cancer Agents Sales by Type (2021-2026) & (tons) Table 183. Europe Plant Sources Anti Cancer Agents Sales by Type (2027-2032) & (tons) Table 184. Europe Plant Sources Anti Cancer Agents Sales Price by Type (2021-2026) & (US$/kg) Table 185. Europe Plant Sources Anti Cancer Agents Sales Price by Type (2027-2032) & (US$/kg) Table 186. Europe Plant Sources Anti Cancer Agents Revenue by Application (2021-2026) & (US$ Million) Table 187. Europe Plant Sources Anti Cancer Agents Revenue by Application (2027-2032) & (US$ Million) Table 188. Europe Plant Sources Anti Cancer Agents Sales by Application (2021-2026) & (tons) Table 189. Europe Plant Sources Anti Cancer Agents Sales by Application (2027-2032) & (tons) Table 190. Europe Plant Sources Anti Cancer Agents Sales Price by Application (2021-2026) & (US$/kg) Table 191. Europe Plant Sources Anti Cancer Agents Sales Price by Application (2027-2032) & (US$/kg) Table 192. Europe Plant Sources Anti Cancer Agents Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 193. Europe Plant Sources Anti Cancer Agents Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 194. Europe Plant Sources Anti Cancer Agents Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 195. Europe Plant Sources Anti Cancer Agents Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 196. Europe Plant Sources Anti Cancer Agents Sales by Country (2021-2026) & (tons) Table 197. Europe Plant Sources Anti Cancer Agents Sales by Country (2027-2032) & (tons) Table 198. Europe Plant Sources Anti Cancer Agents Sales Price by Country (2021-2026) & (US$/kg) Table 199. Europe Plant Sources Anti Cancer Agents Sales Price by Country (2027-2032) & (US$/kg) Table 200. Germany Plant Sources Anti Cancer Agents Revenue (2021-2032) & (US$ Million) Table 201. France Plant Sources Anti Cancer Agents Revenue (2021-2032) & (US$ Million) Table 202. U.K. Plant Sources Anti Cancer Agents Revenue (2021-2032) & (US$ Million) Table 203. Italy Plant Sources Anti Cancer Agents Revenue (2021-2032) & (US$ Million) Table 204. Russia Plant Sources Anti Cancer Agents Revenue (2021-2032) & (US$ Million) Table 205. Spain Plant Sources Anti Cancer Agents Revenue (2021-2032) & (US$ Million) Table 206. Netherlands Plant Sources Anti Cancer Agents Revenue (2021-2032) & (US$ Million) Table 207. Switzerland Plant Sources Anti Cancer Agents Revenue (2021-2032) & (US$ Million) Table 208. Sweden Plant Sources Anti Cancer Agents Revenue (2021-2032) & (US$ Million) Table 209. Poland Plant Sources Anti Cancer Agents Revenue (2021-2032) & (US$ Million) Table 210. China Plant Sources Anti Cancer Agents Revenue by Type (2021-2026) & (US$ Million) Table 211. China Plant Sources Anti Cancer Agents Revenue by Type (2027-2032) & (US$ Million) Table 212. China Plant Sources Anti Cancer Agents Sales by Type (2021-2026) & (tons) Table 213. China Plant Sources Anti Cancer Agents Sales by Type (2027-2032) & (tons) Table 214. China Plant Sources Anti Cancer Agents Sales Price by Type (2021-2026) & (US$/kg) Table 215. China Plant Sources Anti Cancer Agents Sales Price by Type (2027-2032) & (US$/kg) Table 216. China Plant Sources Anti Cancer Agents Revenue by Application (2021-2026) & (US$ Million) Table 217. China Plant Sources Anti Cancer Agents Revenue by Application (2027-2032) & (US$ Million) Table 218. China Plant Sources Anti Cancer Agents Sales by Application (2021-2026) & (tons) Table 219. China Plant Sources Anti Cancer Agents Sales by Application (2027-2032) & (tons) Table 220. China Plant Sources Anti Cancer Agents Sales Price by Application (2021-2026) & (US$/kg) Table 221. China Plant Sources Anti Cancer Agents Sales Price by Application (2027-2032) & (US$/kg) Table 222. Asia Plant Sources Anti Cancer Agents Revenue by Type (2021-2026) & (US$ Million) Table 223. Asia Plant Sources Anti Cancer Agents Revenue by Type (2027-2032) & (US$ Million) Table 224. Asia Plant Sources Anti Cancer Agents Sales by Type (2021-2026) & (tons) Table 225. Asia Plant Sources Anti Cancer Agents Sales by Type (2027-2032) & (tons) Table 226. Asia Plant Sources Anti Cancer Agents Sales Price by Type (2021-2026) & (US$/kg) Table 227. Asia Plant Sources Anti Cancer Agents Sales Price by Type (2027-2032) & (US$/kg) Table 228. Asia Plant Sources Anti Cancer Agents Revenue by Application (2021-2026) & (US$ Million) Table 229. Asia Plant Sources Anti Cancer Agents Revenue by Application (2027-2032) & (US$ Million) Table 230. Asia Plant Sources Anti Cancer Agents Sales by Application (2021-2026) & (tons) Table 231. Asia Plant Sources Anti Cancer Agents Sales by Application (2027-2032) & (tons) Table 232. Asia Plant Sources Anti Cancer Agents Sales Price by Application (2021-2026) & (US$/kg) Table 233. Asia Plant Sources Anti Cancer Agents Sales Price by Application (2027-2032) & (US$/kg) Table 234. Asia Plant Sources Anti Cancer Agents Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 235. Asia Plant Sources Anti Cancer Agents Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 236. Asia Plant Sources Anti Cancer Agents Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 237. Asia Plant Sources Anti Cancer Agents Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 238. Asia Plant Sources Anti Cancer Agents Sales by Country (2021-2026) & (tons) Table 239. Asia Plant Sources Anti Cancer Agents Sales by Country (2027-2032) & (tons) Table 240. Asia Plant Sources Anti Cancer Agents Sales Price by Country (2021-2026) & (US$/kg) Table 241. Asia Plant Sources Anti Cancer Agents Sales Price by Country (2027-2032) & (US$/kg) Table 242. Japan Plant Sources Anti Cancer Agents Revenue (2021-2032) & (US$ Million) Table 243. South Korea Plant Sources Anti Cancer Agents Revenue (2021-2032) & (US$ Million) Table 244. India Plant Sources Anti Cancer Agents Revenue (2021-2032) & (US$ Million) Table 245. Australia Plant Sources Anti Cancer Agents Revenue (2021-2032) & (US$ Million) Table 246. Taiwan Plant Sources Anti Cancer Agents Revenue (2021-2032) & (US$ Million) Table 247. Southeast Asia Plant Sources Anti Cancer Agents Revenue (2021-2032) & (US$ Million) Table 248. SAMEA Plant Sources Anti Cancer Agents Revenue by Type (2021-2026) & (US$ Million) Table 249. SAMEA Plant Sources Anti Cancer Agents Revenue by Type (2027-2032) & (US$ Million) Table 250. SAMEA Plant Sources Anti Cancer Agents Sales by Type (2021-2026) & (tons) Table 251. SAMEA Plant Sources Anti Cancer Agents Sales by Type (2027-2032) & (tons) Table 252. SAMEA Plant Sources Anti Cancer Agents Sales Price by Type (2021-2026) & (US$/kg) Table 253. SAMEA Plant Sources Anti Cancer Agents Sales Price by Type (2027-2032) & (US$/kg) Table 254. SAMEA Plant Sources Anti Cancer Agents Revenue by Application (2021-2026) & (US$ Million) Table 255. SAMEA Plant Sources Anti Cancer Agents Revenue by Application (2027-2032) & (US$ Million) Table 256. SAMEA Plant Sources Anti Cancer Agents Sales by Application (2021-2026) & (tons) Table 257. SAMEA Plant Sources Anti Cancer Agents Sales by Application (2027-2032) & (tons) Table 258. SAMEA Plant Sources Anti Cancer Agents Sales Price by Application (2021-2026) & (US$/kg) Table 259. SAMEA Plant Sources Anti Cancer Agents Sales Price by Application (2027-2032) & (US$/kg) Table 260. SAMEA Plant Sources Anti Cancer Agents Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 261. SAMEA Plant Sources Anti Cancer Agents Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 262. SAMEA Plant Sources Anti Cancer Agents Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 263. SAMEA Plant Sources Anti Cancer Agents Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 264. SAMEA Plant Sources Anti Cancer Agents Sales by Country (2021-2026) & (tons) Table 265. SAMEA Plant Sources Anti Cancer Agents Sales by Country (2027-2032) & (tons) Table 266. SAMEA Plant Sources Anti Cancer Agents Sales Price by Country (2021-2026) & (US$/kg) Table 267. SAMEA Plant Sources Anti Cancer Agents Sales Price by Country (2027-2032) & (US$/kg) Table 268. Brazil Plant Sources Anti Cancer Agents Revenue (2021-2032) & (US$ Million) Table 269. Argentina Plant Sources Anti Cancer Agents Revenue (2021-2032) & (US$ Million) Table 270. Chile Plant Sources Anti Cancer Agents Revenue (2021-2032) & (US$ Million) Table 271. Colombia Plant Sources Anti Cancer Agents Revenue (2021-2032) & (US$ Million) Table 272. Peru Plant Sources Anti Cancer Agents Revenue (2021-2032) & (US$ Million) Table 273. Saudi Arabia Plant Sources Anti Cancer Agents Revenue (2021-2032) & (US$ Million) Table 274. Israel Plant Sources Anti Cancer Agents Revenue (2021-2032) & (US$ Million) Table 275. UAE Plant Sources Anti Cancer Agents Revenue (2021-2032) & (US$ Million) Table 276. Turkey Plant Sources Anti Cancer Agents Revenue (2021-2032) & (US$ Million) Table 277. Iran Plant Sources Anti Cancer Agents Revenue (2021-2032) & (US$ Million) Table 278. Egypt Plant Sources Anti Cancer Agents Revenue (2021-2032) & (US$ Million) Table 279. Key Raw Materials Table 280. Raw Materials Key Suppliers Table 281. Plant Sources Anti Cancer Agents Distributors List Table 282. Plant Sources Anti Cancer Agents Customers List Table 283. Research Programs/Design for This Report Table 284. Authors List of This Report Table 285. Secondary Sources Table 286. Primary Sources List of Figures Figure 1. Plant Sources Anti Cancer Agents Image Figure 2. Global Plant Sources Anti Cancer Agents Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Plant Sources Anti Cancer Agents Market Size Share 2021 VS 2025 VS 2032 Figure 4. Paclitaxel Image Figure 5. Vinorelbine Image Figure 6. Irinotecan Image Figure 7. Hydroxycamptothecin Image Figure 8. Docetaxel Image Figure 9. Other Image Figure 10. Global Plant Sources Anti Cancer Agents Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Plant Sources Anti Cancer Agents Market Size Share 2021 VS 2025 VS 2032 Figure 12. Breast Cancer Image Figure 13. Ovarian Cancer Image Figure 14. Cervical Cancer Image Figure 15. Other Image Figure 16. Global Plant Sources Anti Cancer Agents Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Plant Sources Anti Cancer Agents Revenue (2021-2032) & (US$ Million) Figure 18. Global Plant Sources Anti Cancer Agents Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Plant Sources Anti Cancer Agents Revenue Market Share by Region: 2025 Versus 2032 Figure 20. Global Plant Sources Anti Cancer Agents Revenue Market Share by Region (2021-2032) Figure 21. Global Plant Sources Anti Cancer Agents Sales (2021-2032) & (tons) Figure 22. Global Plant Sources Anti Cancer Agents Sales by Region: 2021 VS 2025 VS 2032 (tons) Figure 23. Global Plant Sources Anti Cancer Agents Sales Market Share by Region (2021-2032) Figure 24. US & Canada & Mexico Plant Sources Anti Cancer Agents Sales YoY (2021-2032) & (tons) Figure 25. Europe Plant Sources Anti Cancer Agents Sales YoY (2021-2032) & (tons) Figure 26. China Plant Sources Anti Cancer Agents Sales YoY (2021-2032) & (tons) Figure 27. Asia (Excluding China) Plant Sources Anti Cancer Agents Sales YoY (2021-2032) & (tons) Figure 28. South America, Middle East and Africa Plant Sources Anti Cancer Agents Sales YoY (2021-2032) & (tons) Figure 29. Global Plant Sources Anti Cancer Agents Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 30. Global Plant Sources Anti Cancer Agents Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 31. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 32. Global Plant Sources Anti Cancer Agents Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Plant Sources Anti Cancer Agents Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Plant Sources Anti Cancer Agents Revenue Market Share by Type (2021-2032) Figure 35. Global Plant Sources Anti Cancer Agents Sales by Type (2021 VS 2025 VS 2032) & (tons) Figure 36. Global Plant Sources Anti Cancer Agents Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 37. Global Plant Sources Anti Cancer Agents Sales Market Share by Type (2021-2032) Figure 38. Global Plant Sources Anti Cancer Agents Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 39. Global Plant Sources Anti Cancer Agents Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Plant Sources Anti Cancer Agents Revenue Market Share by Application (2021-2032) Figure 41. Global Plant Sources Anti Cancer Agents Sales by Application (2021 VS 2025 VS 2032) & (tons) Figure 42. Global Plant Sources Anti Cancer Agents Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 43. Global Plant Sources Anti Cancer Agents Sales Market Share by Application (2021-2032) Figure 44. North America Plant Sources Anti Cancer Agents Revenue Share by Type (2021-2032) Figure 45. North America Plant Sources Anti Cancer Agents Sales Share by Type (2021-2032) Figure 46. North America Plant Sources Anti Cancer Agents Revenue Share by Application (2021-2032) Figure 47. North America Plant Sources Anti Cancer Agents Sales Share by Application (2021-2032) Figure 48. North America Plant Sources Anti Cancer Agents Revenue Share by Country (2021-2032) Figure 49. North America Plant Sources Anti Cancer Agents Sales Share by Country (2021-2032) Figure 50. Europe Plant Sources Anti Cancer Agents Revenue Share by Type (2021-2032) Figure 51. Europe Plant Sources Anti Cancer Agents Sales Share by Type (2021-2032) Figure 52. Europe Plant Sources Anti Cancer Agents Revenue Share by Application (2021-2032) Figure 53. Europe Plant Sources Anti Cancer Agents Sales Share by Application (2021-2032) Figure 54. Europe Plant Sources Anti Cancer Agents Revenue Share by Country (2021-2032) Figure 55. Europe Plant Sources Anti Cancer Agents Sales Share by Country (2021-2032) Figure 56. China Plant Sources Anti Cancer Agents Revenue Share by Type (2021-2032) Figure 57. China Plant Sources Anti Cancer Agents Sales Share by Type (2021-2032) Figure 58. China Plant Sources Anti Cancer Agents Revenue Share by Application (2021-2032) Figure 59. China Plant Sources Anti Cancer Agents Sales Share by Application (2021-2032) Figure 60. Asia Plant Sources Anti Cancer Agents Revenue Share by Type (2021-2032) Figure 61. Asia Plant Sources Anti Cancer Agents Sales Share by Type (2021-2032) Figure 62. Asia Plant Sources Anti Cancer Agents Revenue Share by Application (2021-2032) Figure 63. Asia Plant Sources Anti Cancer Agents Sales Share by Application (2021-2032) Figure 64. Asia Plant Sources Anti Cancer Agents Revenue Share by Country (2021-2032) Figure 65. Asia Plant Sources Anti Cancer Agents Sales Share by Country (2021-2032) Figure 66. SAMEA Plant Sources Anti Cancer Agents Revenue Share by Type (2021-2032) Figure 67. SAMEA Plant Sources Anti Cancer Agents Sales Share by Type (2021-2032) Figure 68. SAMEA Plant Sources Anti Cancer Agents Revenue Share by Application (2021-2032) Figure 69. SAMEA Plant Sources Anti Cancer Agents Sales Share by Application (2021-2032) Figure 70. SAMEA Plant Sources Anti Cancer Agents Revenue Share by Country (2021-2032) Figure 71. SAMEA Plant Sources Anti Cancer Agents Sales Share by Country (2021-2032) Figure 72. Plant Sources Anti Cancer Agents Value Chain Figure 73. Manufacturing Cost Structure Figure 74. Plant Sources Anti Cancer Agents Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Paclitaxel
  • Vinorelbine
  • Irinotecan
  • Hydroxycamptothecin
  • Docetaxel
  • Other
Applications
  • Breast Cancer
  • Ovarian Cancer
  • Cervical Cancer
  • Other
Companies covered
  • Yunnan Hande
  • Pfizer
  • Hainan Yew Pharm
  • West-Ward Pharmaceuticals
  • TAPI (Teva)
  • Taj Pharma
  • Southpharma
  • ScinoPharm
  • Samyang
  • Salius
  • Polymed
  • Phyton
  • Novasep
  • Jiangsu Yew Biotechnology
  • Huiang biopharma
  • Getwell
  • Fresenius-kabi
  • Cipla
  • Actiza Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Plant Sources Anti Cancer Agents Market by Type
  3. 1.2.1 Global Plant Sources Anti Cancer Agents Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Paclitaxel
  5. 1.2.3 Vinorelbine
  6. 1.2.4 Irinotecan
  7. 1.2.5 Hydroxycamptothecin
  8. 1.2.6 Docetaxel
  9. 1.2.7 Other
  10. 1.3 Plant Sources Anti Cancer Agents Market by Application
  11. 1.3.1 Global Plant Sources Anti Cancer Agents Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Breast Cancer
  13. 1.3.3 Ovarian Cancer
  14. 1.3.4 Cervical Cancer
  15. 1.3.5 Other
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Plant Sources Anti Cancer Agents Market Dynamics
  1. 2.1 Plant Sources Anti Cancer Agents Industry Trends
  2. 2.2 Plant Sources Anti Cancer Agents Industry Drivers
  3. 2.3 Plant Sources Anti Cancer Agents Industry Opportunities and Challenges
  4. 2.4 Plant Sources Anti Cancer Agents Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Plant Sources Anti Cancer Agents Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Plant Sources Anti Cancer Agents Revenue by Region
  3. 3.2.1 Global Plant Sources Anti Cancer Agents Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Plant Sources Anti Cancer Agents Revenue by Region (2021-2026)
  5. 3.2.3 Global Plant Sources Anti Cancer Agents Revenue by Region (2027-2032)
  6. 3.2.4 Global Plant Sources Anti Cancer Agents Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Plant Sources Anti Cancer Agents Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Plant Sources Anti Cancer Agents Sales by Region
  9. 3.4.1 Global Plant Sources Anti Cancer Agents Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Plant Sources Anti Cancer Agents Sales by Region (2021-2026)
  11. 3.4.3 Global Plant Sources Anti Cancer Agents Sales by Region (2027-2032)
  12. 3.4.4 Global Plant Sources Anti Cancer Agents Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Plant Sources Anti Cancer Agents Revenue by Manufacturers
  2. 4.1.1 Global Plant Sources Anti Cancer Agents Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Plant Sources Anti Cancer Agents Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Plant Sources Anti Cancer Agents Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Plant Sources Anti Cancer Agents Sales by Manufacturers
  6. 4.2.1 Global Plant Sources Anti Cancer Agents Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Plant Sources Anti Cancer Agents Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Plant Sources Anti Cancer Agents Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Plant Sources Anti Cancer Agents Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Plant Sources Anti Cancer Agents Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Plant Sources Anti Cancer Agents Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Plant Sources Anti Cancer Agents Manufacturers, Product Type & Application
  13. 4.7 Global Plant Sources Anti Cancer Agents Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Plant Sources Anti Cancer Agents Market CR5 and HHI
  16. 4.8.2 2025 Plant Sources Anti Cancer Agents Tier 1, Tier 2, and Tier 3
5 Plant Sources Anti Cancer Agents Market by Type
  1. 5.1 Global Plant Sources Anti Cancer Agents Revenue by Type
  2. 5.1.1 Global Plant Sources Anti Cancer Agents Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Plant Sources Anti Cancer Agents Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Plant Sources Anti Cancer Agents Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Plant Sources Anti Cancer Agents Sales by Type
  6. 5.2.1 Global Plant Sources Anti Cancer Agents Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Plant Sources Anti Cancer Agents Sales by Type (2021-2032) & (tons)
  8. 5.2.3 Global Plant Sources Anti Cancer Agents Sales Market Share by Type (2021-2032)
  9. 5.3 Global Plant Sources Anti Cancer Agents Price by Type
6 Plant Sources Anti Cancer Agents Market by Application
  1. 6.1 Global Plant Sources Anti Cancer Agents Revenue by Application
  2. 6.1.1 Global Plant Sources Anti Cancer Agents Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Plant Sources Anti Cancer Agents Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Plant Sources Anti Cancer Agents Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Plant Sources Anti Cancer Agents Sales by Application
  6. 6.2.1 Global Plant Sources Anti Cancer Agents Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Plant Sources Anti Cancer Agents Sales by Application (2021-2032) & (tons)
  8. 6.2.3 Global Plant Sources Anti Cancer Agents Sales Market Share by Application (2021-2032)
  9. 6.3 Global Plant Sources Anti Cancer Agents Price by Application
7 Company Profiles
  1. 7.1 Yunnan Hande
  2. 7.1.1 Yunnan Hande Company Information
  3. 7.1.2 Yunnan Hande Business Overview
  4. 7.1.3 Yunnan Hande Plant Sources Anti Cancer Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Yunnan Hande Plant Sources Anti Cancer Agents Product Portfolio
  6. 7.1.5 Yunnan Hande Recent Developments
  7. 7.2 Pfizer
  8. 7.2.1 Pfizer Company Information
  9. 7.2.2 Pfizer Business Overview
  10. 7.2.3 Pfizer Plant Sources Anti Cancer Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Pfizer Plant Sources Anti Cancer Agents Product Portfolio
  12. 7.2.5 Pfizer Recent Developments
  13. 7.3 Hainan Yew Pharm
  14. 7.3.1 Hainan Yew Pharm Company Information
  15. 7.3.2 Hainan Yew Pharm Business Overview
  16. 7.3.3 Hainan Yew Pharm Plant Sources Anti Cancer Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Hainan Yew Pharm Plant Sources Anti Cancer Agents Product Portfolio
  18. 7.3.5 Hainan Yew Pharm Recent Developments
  19. 7.4 West-Ward Pharmaceuticals
  20. 7.4.1 West-Ward Pharmaceuticals Company Information
  21. 7.4.2 West-Ward Pharmaceuticals Business Overview
  22. 7.4.3 West-Ward Pharmaceuticals Plant Sources Anti Cancer Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 West-Ward Pharmaceuticals Plant Sources Anti Cancer Agents Product Portfolio
  24. 7.4.5 West-Ward Pharmaceuticals Recent Developments
  25. 7.5 TAPI (Teva)
  26. 7.5.1 TAPI (Teva) Company Information
  27. 7.5.2 TAPI (Teva) Business Overview
  28. 7.5.3 TAPI (Teva) Plant Sources Anti Cancer Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 TAPI (Teva) Plant Sources Anti Cancer Agents Product Portfolio
  30. 7.5.5 TAPI (Teva) Recent Developments
  31. 7.6 Taj Pharma
  32. 7.6.1 Taj Pharma Company Information
  33. 7.6.2 Taj Pharma Business Overview
  34. 7.6.3 Taj Pharma Plant Sources Anti Cancer Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Taj Pharma Plant Sources Anti Cancer Agents Product Portfolio
  36. 7.6.5 Taj Pharma Recent Developments
  37. 7.7 Southpharma
  38. 7.7.1 Southpharma Company Information
  39. 7.7.2 Southpharma Business Overview
  40. 7.7.3 Southpharma Plant Sources Anti Cancer Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Southpharma Plant Sources Anti Cancer Agents Product Portfolio
  42. 7.7.5 Southpharma Recent Developments
  43. 7.8 ScinoPharm
  44. 7.8.1 ScinoPharm Company Information
  45. 7.8.2 ScinoPharm Business Overview
  46. 7.8.3 ScinoPharm Plant Sources Anti Cancer Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 ScinoPharm Plant Sources Anti Cancer Agents Product Portfolio
  48. 7.8.5 ScinoPharm Recent Developments
  49. 7.9 Samyang
  50. 7.9.1 Samyang Company Information
  51. 7.9.2 Samyang Business Overview
  52. 7.9.3 Samyang Plant Sources Anti Cancer Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Samyang Plant Sources Anti Cancer Agents Product Portfolio
  54. 7.9.5 Samyang Recent Developments
  55. 7.10 Salius
  56. 7.10.1 Salius Company Information
  57. 7.10.2 Salius Business Overview
  58. 7.10.3 Salius Plant Sources Anti Cancer Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Salius Plant Sources Anti Cancer Agents Product Portfolio
  60. 7.10.5 Salius Recent Developments
  61. 7.11 Polymed
  62. 7.11.1 Polymed Company Information
  63. 7.11.2 Polymed Business Overview
  64. 7.11.3 Polymed Plant Sources Anti Cancer Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Polymed Plant Sources Anti Cancer Agents Product Portfolio
  66. 7.11.5 Polymed Recent Developments
  67. 7.12 Phyton
  68. 7.12.1 Phyton Company Information
  69. 7.12.2 Phyton Business Overview
  70. 7.12.3 Phyton Plant Sources Anti Cancer Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Phyton Plant Sources Anti Cancer Agents Product Portfolio
  72. 7.12.5 Phyton Recent Developments
  73. 7.13 Novasep
  74. 7.13.1 Novasep Company Information
  75. 7.13.2 Novasep Business Overview
  76. 7.13.3 Novasep Plant Sources Anti Cancer Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Novasep Plant Sources Anti Cancer Agents Product Portfolio
  78. 7.13.5 Novasep Recent Developments
  79. 7.14 Jiangsu Yew Biotechnology
  80. 7.14.1 Jiangsu Yew Biotechnology Company Information
  81. 7.14.2 Jiangsu Yew Biotechnology Business Overview
  82. 7.14.3 Jiangsu Yew Biotechnology Plant Sources Anti Cancer Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Jiangsu Yew Biotechnology Plant Sources Anti Cancer Agents Product Portfolio
  84. 7.14.5 Jiangsu Yew Biotechnology Recent Developments
  85. 7.15 Huiang biopharma
  86. 7.15.1 Huiang biopharma Company Information
  87. 7.15.2 Huiang biopharma Business Overview
  88. 7.15.3 Huiang biopharma Plant Sources Anti Cancer Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Huiang biopharma Plant Sources Anti Cancer Agents Product Portfolio
  90. 7.15.5 Huiang biopharma Recent Developments
  91. 7.16 Getwell
  92. 7.16.1 Getwell Company Information
  93. 7.16.2 Getwell Business Overview
  94. 7.16.3 Getwell Plant Sources Anti Cancer Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Getwell Plant Sources Anti Cancer Agents Product Portfolio
  96. 7.16.5 Getwell Recent Developments
  97. 7.17 Fresenius-kabi
  98. 7.17.1 Fresenius-kabi Company Information
  99. 7.17.2 Fresenius-kabi Business Overview
  100. 7.17.3 Fresenius-kabi Plant Sources Anti Cancer Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Fresenius-kabi Plant Sources Anti Cancer Agents Product Portfolio
  102. 7.17.5 Fresenius-kabi Recent Developments
  103. 7.18 Cipla
  104. 7.18.1 Cipla Company Information
  105. 7.18.2 Cipla Business Overview
  106. 7.18.3 Cipla Plant Sources Anti Cancer Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Cipla Plant Sources Anti Cancer Agents Product Portfolio
  108. 7.18.5 Cipla Recent Developments
  109. 7.19 Actiza Pharmaceutical
  110. 7.19.1 Actiza Pharmaceutical Company Information
  111. 7.19.2 Actiza Pharmaceutical Business Overview
  112. 7.19.3 Actiza Pharmaceutical Plant Sources Anti Cancer Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Actiza Pharmaceutical Plant Sources Anti Cancer Agents Product Portfolio
  114. 7.19.5 Actiza Pharmaceutical Recent Developments
8 North America
  1. 8.1 North America Plant Sources Anti Cancer Agents Market Size by Type
  2. 8.1.1 North America Plant Sources Anti Cancer Agents Revenue by Type (2021-2032)
  3. 8.1.2 North America Plant Sources Anti Cancer Agents Sales by Type (2021-2032)
  4. 8.1.3 North America Plant Sources Anti Cancer Agents Price by Type (2021-2032)
  5. 8.2 North America Plant Sources Anti Cancer Agents Market Size by Application
  6. 8.2.1 North America Plant Sources Anti Cancer Agents Revenue by Application (2021-2032)
  7. 8.2.2 North America Plant Sources Anti Cancer Agents Sales by Application (2021-2032)
  8. 8.2.3 North America Plant Sources Anti Cancer Agents Price by Application (2021-2032)
  9. 8.3 North America Plant Sources Anti Cancer Agents Market Size by Country
  10. 8.3.1 North America Plant Sources Anti Cancer Agents Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Plant Sources Anti Cancer Agents Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Plant Sources Anti Cancer Agents Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Plant Sources Anti Cancer Agents Market Size by Type
  2. 9.1.1 Europe Plant Sources Anti Cancer Agents Revenue by Type (2021-2032)
  3. 9.1.2 Europe Plant Sources Anti Cancer Agents Sales by Type (2021-2032)
  4. 9.1.3 Europe Plant Sources Anti Cancer Agents Price by Type (2021-2032)
  5. 9.2 Europe Plant Sources Anti Cancer Agents Market Size by Application
  6. 9.2.1 Europe Plant Sources Anti Cancer Agents Revenue by Application (2021-2032)
  7. 9.2.2 Europe Plant Sources Anti Cancer Agents Sales by Application (2021-2032)
  8. 9.2.3 Europe Plant Sources Anti Cancer Agents Price by Application (2021-2032)
  9. 9.3 Europe Plant Sources Anti Cancer Agents Market Size by Country
  10. 9.3.1 Europe Plant Sources Anti Cancer Agents Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Plant Sources Anti Cancer Agents Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Plant Sources Anti Cancer Agents Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Plant Sources Anti Cancer Agents Market Size by Type
  2. 10.1.1 China Plant Sources Anti Cancer Agents Revenue by Type (2021-2032)
  3. 10.1.2 China Plant Sources Anti Cancer Agents Sales by Type (2021-2032)
  4. 10.1.3 China Plant Sources Anti Cancer Agents Price by Type (2021-2032)
  5. 10.2 China Plant Sources Anti Cancer Agents Market Size by Application
  6. 10.2.1 China Plant Sources Anti Cancer Agents Revenue by Application (2021-2032)
  7. 10.2.2 China Plant Sources Anti Cancer Agents Sales by Application (2021-2032)
  8. 10.2.3 China Plant Sources Anti Cancer Agents Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Plant Sources Anti Cancer Agents Market Size by Type
  2. 11.1.1 Asia Plant Sources Anti Cancer Agents Revenue by Type (2021-2032)
  3. 11.1.2 Asia Plant Sources Anti Cancer Agents Sales by Type (2021-2032)
  4. 11.1.3 Asia Plant Sources Anti Cancer Agents Price by Type (2021-2032)
  5. 11.2 Asia Plant Sources Anti Cancer Agents Market Size by Application
  6. 11.2.1 Asia Plant Sources Anti Cancer Agents Revenue by Application (2021-2032)
  7. 11.2.2 Asia Plant Sources Anti Cancer Agents Sales by Application (2021-2032)
  8. 11.2.3 Asia Plant Sources Anti Cancer Agents Price by Application (2021-2032)
  9. 11.3 Asia Plant Sources Anti Cancer Agents Market Size by Country
  10. 11.3.1 Asia Plant Sources Anti Cancer Agents Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Plant Sources Anti Cancer Agents Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Plant Sources Anti Cancer Agents Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Plant Sources Anti Cancer Agents Market Size by Type
  2. 12.1.1 SAMEA Plant Sources Anti Cancer Agents Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Plant Sources Anti Cancer Agents Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Plant Sources Anti Cancer Agents Price by Type (2021-2032)
  5. 12.2 SAMEA Plant Sources Anti Cancer Agents Market Size by Application
  6. 12.2.1 SAMEA Plant Sources Anti Cancer Agents Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Plant Sources Anti Cancer Agents Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Plant Sources Anti Cancer Agents Price by Application (2021-2032)
  9. 12.3 SAMEA Plant Sources Anti Cancer Agents Market Size by Country
  10. 12.3.1 SAMEA Plant Sources Anti Cancer Agents Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Plant Sources Anti Cancer Agents Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Plant Sources Anti Cancer Agents Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Plant Sources Anti Cancer Agents Value Chain Analysis
  2. 13.1.1 Plant Sources Anti Cancer Agents Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Plant Sources Anti Cancer Agents Production Mode & Process
  6. 13.2 Plant Sources Anti Cancer Agents Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Plant Sources Anti Cancer Agents Distributors
  9. 13.2.3 Plant Sources Anti Cancer Agents Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst